References
- RogersSMcIntoshRLJournGDThe prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and AustraliaOphthalmology201011731331920022117
- The Branch Vein Occlusion Study GroupArgon laser photocoagulation for macular edema in branch vein occlusionAm J Ophthalmol1984982712826383055
- The Central Vein Occlusion Study GroupEvaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M reportOphthalmology1995102142514339097788
- LeopoldIHNonsteroidal and steroidal anti-inflammatory agentsSearsMlTarkkanenASurgical Pharmacology of the EyeNew YorkRaven Press198583133
- IpMSScottIUVanVeldhuisenPCA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5Arch Ophthalmol20091271101111419752419
- ScottIUIpMSVanVeldhuisenPCA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6Arch Ophthalmol20091271115112819752420
- EdelmanJLDifferentiating intraocular glucocor ticoidsOphthalmologica2010224Suppl 1253020714178
- GanIMUgaharyLCvan DisselJTvan MeursJCEffect of intravitreal dexamethasone on vitreous vancomycin concentrations in patients with suspected postoperative bacterial endophthalmitisGraefes Arch Clin Exp Ophthalmol20052431186118915906066
- Chang-LinJEAttarMAcheampongAAPharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implantInvest Ophthalmol Vis Sci201152808620702826
- KunoNFujiiSBiodegradable intraocular therapies for retinal disorders: progress to dateDrugs Aging20102711713420104938
- YasukawaTOguraYTabataYKimuraHWiedemannPHondaYDrug delivery systems for vitreoretinal diseasesProg Retin Eye Res20042325328115177203
- HallerJABandelloFBelfortRRandomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein OcclusionOphthalmol201011711341146
- CampochiaroPAHeierJSFeinerLRanibizumab for macular edema following branch retinal vein occlusionOphthalmology20101171102111220398941
- BrownDMCampochiaroPASinghRPRanibizumab for macular edema following central retinal vein occlusionOphthalmology20101171124113320381871
- VisscherGERobisonRLMauldingHVBiodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsulesJ Biomed Mater Res1985193493654077887
- MoriteraTOguraYHondaYMicrospheres of biodegradable polymers as a drug-delivery system in the vitreousInvest Ophthalmol Vis Sci199132178517902032801
- FialhoSLRegoMBSiqueiraRCSafety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyesCurr Eye Res20063152553416769612
- NabihMPeymanGATawakolMENaguibKToxicity of high-dose intravitreal dexamethasoneInt Ophthalmol1991152332351917317
- KwakHWD’AmicoDJEvaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injectionArch Ophthalmol19921102592661736876
- KuppermannBDBlumenkranzMSHallerJARandomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edemaArch Ophthalmol200712530931717353400
- HallerJADugelPWeinbergDVEvaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edemaRetina200929465118827732
- DeramoVACoxTASyedABVision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function QuestionnaireArch Ophthalmol20031211297130212963613
- AwdehRMElsingSHDeramoVAVision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item National Eye Institute Visual Function QuestionnaireBr J Ophthalmol20109431932319737736
- ChangMAFineHFBassEPatients’ preferences in choosing therapy for retinal vein occlusionsRetina20072778979717621191
- CampochiaroPAHeierJSFeinerLRanibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III studyOphthalmology20101171102e11112e120398941
- BrownDMCampochiaroPASinghRPRanibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III studyOphthalmology20101171124e11133e120381871
- BeerPMBakriSJSinghRJIntraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injectionOphthalmology200311068168612689886
- MasonJOSomaiyaMDSinghRJIntravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyesRetina20042490090415579987